SPA to oppose the quasi-drug expansion policy.

Published: 2005-07-20 06:59:00

Updated: 2005-07-20 06:59:00

The Seoul Pharmaceutical Association (SPA) made it clear in the 1st meeting of "the Special Committee Against Quasi-Drug Expansion" on July 14 that the MOHW's policy of expanding the quasi-drugs be never acceptable.

The Committee rather requested for more expansion of non-prescription drugs f...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK